Cerebrospinal Fluid NLRP3 is Increased After Severe Traumatic Brain Injury in Infants and Children
暂无分享,去创建一个
P. Kochanek | R. Clark | H. Bayır | M. Bell | J. Wallisch | Dennis W. Simon
[1] Committee on Child Abuse and Neglect , 2016, Pediatric Clinical Practice Guidelines & Policies.
[2] Michael Y. Wang,et al. Exosome‐mediated inflammasome signaling after central nervous system injury , 2016, Journal of neurochemistry.
[3] P. Kochanek,et al. Cerebrospinal Fluid Markers of Macrophage and Lymphocyte Activation After Traumatic Brain Injury in Children , 2015, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[4] K. Schroder,et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases , 2015, Nature Medicine.
[5] P. A. Crawford,et al. Ketone body β-hydroxybutyrate blocks the NLRP3 inflammasome-mediated inflammatory disease , 2015, Nature Medicine.
[6] P. A. Crawford,et al. The ketone metabolite β-hydroxybutyrate blocks NLRP 3 inflammasome – mediated inflammatory disease , 2015 .
[7] J. P. de Rivero Vaccari,et al. Activation and Regulation of Cellular Inflammasomes: Gaps in Our Knowledge for Central Nervous System Injury , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[8] J. Pickard,et al. Recombinant Human Interleukin-1 Receptor Antagonist in Severe Traumatic Brain Injury: A Phase II Randomized Control Trial , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[9] D. Angus,et al. Hospitalizations of Children With Neurologic Disorders in the United States , 2013, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[10] C. Hang,et al. Expression of the NLRP3 Inflammasome in Cerebral Cortex After Traumatic Brain Injury in a Rat Model , 2013, Neurochemical Research.
[11] John Beca,et al. Comparison of hypothermia and normothermia after severe traumatic brain injury in children (Cool Kids): a phase 3, randomised controlled trial , 2013, The Lancet Neurology.
[12] E. Latz,et al. Activation and regulation of the inflammasomes , 2013, Nature Reviews Immunology.
[13] J. P. de Rivero Vaccari,et al. Inflammasome proteins in cerebrospinal fluid of brain-injured patients as biomarkers of functional outcome: clinical article. , 2012, Journal of neurosurgery.
[14] E. Tyler-Kabara,et al. Risk factors for mortality in children with abusive head trauma. , 2012, The Journal of pediatrics.
[15] G. López-Castejón,et al. NLRP3-Inflammasome Activating DAMPs Stimulate an Inflammatory Response in Glia in the Absence of Priming Which Contributes to Brain Inflammation after Injury , 2012, Front. Immun..
[16] N. Kissoon,et al. Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents--second edition. , 2012, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[17] Xiangmei Zhou,et al. A role for mitochondria in NLRP3 inflammasome activation , 2011, Nature.
[18] N. Marklund,et al. Neutralization of interleukin‐1β reduces cerebral edema and tissue loss and improves late cognitive outcome following traumatic brain injury in mice , 2011, The European journal of neuroscience.
[19] M. Wald,et al. Surveillance for traumatic brain injury-related deaths--United States, 1997-2007. , 2011, Morbidity and mortality weekly report. Surveillance summaries.
[20] J. A. Llompart-Pou,et al. Lack of correlation among intracerebral cytokines, intracranial pressure, and brain tissue oxygenation in patients with traumatic brain injury and diffuse lesions* , 2011, Critical care medicine.
[21] J. Pickard,et al. The Cytokine Response to Human Traumatic Brain Injury: Temporal Profiles and Evidence for Cerebral Parenchymal Production , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[22] C. Mclean,et al. In situ detection of inflammatory mediators in post mortem human brain tissue after traumatic injury. , 2010, Journal of neurotrauma.
[23] A. Kemp,et al. What are the clinical and radiological characteristics of spinal injuries from physical abuse: a systematic review , 2009, Archives of Disease in Childhood.
[24] V. Dixit,et al. Glyburide inhibits the Cryopyrin/Nalp3 inflammasome , 2009, The Journal of cell biology.
[25] N. Marklund,et al. Neutralization of interleukin‐1β modifies the inflammatory response and improves histological and cognitive outcome following traumatic brain injury in mice , 2009, The European journal of neuroscience.
[26] C. Christian,et al. Abusive Head Trauma in Infants and Children , 2009, Pediatrics.
[27] H. Bramlett,et al. Therapeutic Neutralization of the NLRP1 Inflammasome Reduces the Innate Immune Response and Improves Histopathology after Traumatic Brain Injury , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[28] B. Cookson,et al. Pyroptosis: host cell death and inflammation , 2009, Nature Reviews Microbiology.
[29] B. Cookson,et al. Anthrax lethal toxin and Salmonella elicit the common cell death pathway of caspase-1-dependent pyroptosis via distinct mechanisms , 2008, Proceedings of the National Academy of Sciences.
[30] J. Pickard,et al. Inflammation in Human Brain Injury: Intracerebral Concentrations of IL-1α, IL-1β, and Their Endogenous Inhibitor IL-1ra , 2007 .
[31] P. Stahel,et al. Activation of caspase-1 dependent interleukins in developmental brain trauma , 2007, Neurobiology of Disease.
[32] J. Pickard,et al. Inflammation in human brain injury: intracerebral concentrations of IL-1alpha, IL-1beta, and their endogenous inhibitor IL-1ra. , 2007, Journal of neurotrauma.
[33] O. Tasaki,et al. CEREBROSPINAL FLUID CONCENTRATIONS OF ANTI-INFLAMMATORY MEDIATORS IN EARLY-PHASE SEVERE TRAUMATIC BRAIN INJURY , 2005, Shock.
[34] S. Wisniewski,et al. Cytochrome c, a Biomarker of Apoptosis, is Increased in Cerebrospinal Fluid from Infants with Inflicted Brain Injury from Child Abuse , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[35] M. Piastra,et al. Interleukin 1β and interleukin 6 relationship with paediatric head trauma severity and outcome , 2005, Child's Nervous System.
[36] M. Morganti-Kossmann,et al. Tumor necrosis factor-mediated inhibition of interleukin-18 in the brain: a clinical and experimental study in head-injured patients and in a murine model of closed head injury. , 2004, Journal of Neuroinflammation.
[37] F. Martinon,et al. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. , 2002, Molecular cell.
[38] T. Bártfai,et al. Improved recovery and delayed cytokine induction after closed head injury in mice with central overexpression of the secreted isoform of the interleukin-1 receptor antagonist. , 2002, Journal of neurotrauma.
[39] C. Dinarello,et al. Elevated Intracranial IL-18 in Humans and Mice after Traumatic Brain Injury and Evidence of Neuroprotective Effects of IL-18—Binding Protein after Experimental Closed Head Injury , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[40] P. Stieg,et al. Reduction of post-traumatic brain injury and free radical production by inhibition of the caspase-1 cascade , 1999, Neuroscience.
[41] M. Klauber,et al. Outcome from head injury related to patient's age. A longitudinal prospective study of adult and pediatric head injury. , 1988, Journal of Neurosurgery.